MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy

Dong Zhang, Zonghuan Li, Zheng Wang, Fanwei Zeng, Weidong Xiao, Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, People’s Republic of ChinaCorrespondence: Weidong Xiao; Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, No....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang D, Li Z, Wang Z, Zeng F, Xiao W, Yu A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/bb5746ef4add43fbbb3aab973981ee35
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb5746ef4add43fbbb3aab973981ee35
record_format dspace
spelling oai:doaj.org-article:bb5746ef4add43fbbb3aab973981ee352021-12-02T01:54:16ZMicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy1178-7007https://doaj.org/article/bb5746ef4add43fbbb3aab973981ee352019-09-01T00:00:00Zhttps://www.dovepress.com/microrna-126-a-promising-biomarker-for-angiogenesis-of-diabetic-wounds-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Dong Zhang, Zonghuan Li, Zheng Wang, Fanwei Zeng, Weidong Xiao, Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, People’s Republic of ChinaCorrespondence: Weidong Xiao; Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang district, Wuhan, Hubei 430071, People’s Republic of ChinaTel +86 1 870 718 2868; +86 1 350 718 7489Email 1539562641@qq.com yuaixi@whu.edu.cnBackground: Negative pressure wound therapy represents an effective therapy to treat nonhealing diabetic wounds by promoting angiogenesis, of which the mechanism hasn’t been investigated thoroughly. Growing evidence suggests that miRNAs hold great potential to be clinical biomarkers, and miR-126 is an essential angiogenesis regulator in diabetic wound repair.Purpose: Our study aims to explore the effect of NPWT on the expression of miR-126 in the wound tissue and plasma of diabetic rat models and the association between circulating miR-126 and two quantitative indexes of angiogenesis.Methods: Full-thickness excisional wounds were created on the back of diabetic rats. Measure the wound closure and collect the wound tissue and blood for H&E, immunohistochemistry, Western blot and RT-PCR. Here we demonstrated that significantly increased capillary density and arteriolar density in the NPWT group at each specified time-point.Results: In the NPWT group, miR-126 expression was significantly increased on days 3, 5, 7, and 9 (P<0.05). Furthermore, statistically significant increases in VEGF mRNA and protein expression and p-ERK expression, as well as decreased SPRED1 expression, were noted upon treatment with NPWT on day 9. Our data revealed that miR-126 expression in the wound and plasma was significantly associated (P<0.05). Moreover, a positive correlation was also detected between increased levels of circulating miR-126 and arteriolar density, as well as capillary density (P<0.05).Conclusion: The study suggested that miR-126 was upregulated by NPWT and could represent a promising monitoring tool for angiogenesis in diabetic wounds treated with NPWT.Keywords: microRNA-126, negative-pressure wound therapy, diabetic wound healingZhang DLi ZWang ZZeng FXiao WYu ADove Medical PressarticlemicroRNA-126negative-pressure wound therapydiabetic wound healingSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1685-1696 (2019)
institution DOAJ
collection DOAJ
language EN
topic microRNA-126
negative-pressure wound therapy
diabetic wound healing
Specialties of internal medicine
RC581-951
spellingShingle microRNA-126
negative-pressure wound therapy
diabetic wound healing
Specialties of internal medicine
RC581-951
Zhang D
Li Z
Wang Z
Zeng F
Xiao W
Yu A
MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
description Dong Zhang, Zonghuan Li, Zheng Wang, Fanwei Zeng, Weidong Xiao, Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, People’s Republic of ChinaCorrespondence: Weidong Xiao; Aixi YuDepartment of Orthopedics, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang district, Wuhan, Hubei 430071, People’s Republic of ChinaTel +86 1 870 718 2868; +86 1 350 718 7489Email 1539562641@qq.com yuaixi@whu.edu.cnBackground: Negative pressure wound therapy represents an effective therapy to treat nonhealing diabetic wounds by promoting angiogenesis, of which the mechanism hasn’t been investigated thoroughly. Growing evidence suggests that miRNAs hold great potential to be clinical biomarkers, and miR-126 is an essential angiogenesis regulator in diabetic wound repair.Purpose: Our study aims to explore the effect of NPWT on the expression of miR-126 in the wound tissue and plasma of diabetic rat models and the association between circulating miR-126 and two quantitative indexes of angiogenesis.Methods: Full-thickness excisional wounds were created on the back of diabetic rats. Measure the wound closure and collect the wound tissue and blood for H&E, immunohistochemistry, Western blot and RT-PCR. Here we demonstrated that significantly increased capillary density and arteriolar density in the NPWT group at each specified time-point.Results: In the NPWT group, miR-126 expression was significantly increased on days 3, 5, 7, and 9 (P<0.05). Furthermore, statistically significant increases in VEGF mRNA and protein expression and p-ERK expression, as well as decreased SPRED1 expression, were noted upon treatment with NPWT on day 9. Our data revealed that miR-126 expression in the wound and plasma was significantly associated (P<0.05). Moreover, a positive correlation was also detected between increased levels of circulating miR-126 and arteriolar density, as well as capillary density (P<0.05).Conclusion: The study suggested that miR-126 was upregulated by NPWT and could represent a promising monitoring tool for angiogenesis in diabetic wounds treated with NPWT.Keywords: microRNA-126, negative-pressure wound therapy, diabetic wound healing
format article
author Zhang D
Li Z
Wang Z
Zeng F
Xiao W
Yu A
author_facet Zhang D
Li Z
Wang Z
Zeng F
Xiao W
Yu A
author_sort Zhang D
title MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
title_short MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
title_full MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
title_fullStr MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
title_full_unstemmed MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
title_sort microrna-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/bb5746ef4add43fbbb3aab973981ee35
work_keys_str_mv AT zhangd microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
AT liz microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
AT wangz microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
AT zengf microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
AT xiaow microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
AT yua microrna126apromisingbiomarkerforangiogenesisofdiabeticwoundstreatedwithnegativepressurewoundtherapy
_version_ 1718402864298065920